One of Kite Pharma’s CAR-T patients died from cerebral edema, triggering a safety alarm
Kite Pharma revealed today that one of the patients in their late-stage program for the CAR-T drug KTE-C19 died from cerebral edema, the same brain …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
